Health Canada Approves TEVIMBRA® (tislelizumab for injection) in Combination with Gemcitabine and Cisplatin for the First-Line Treatment of Adult Patients with Recurr…

BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), ...

Kindle Scribe Colorsoft vs ReMarkable Paper Pro: Which is best for you?

The Kindle Scribe Colorsoft and the ReMarkable Paper Pro both let you read e-books, take notes and mark up text in color. However, there are some key differences between the Kindle Scribe Colorsoft vs ...

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response R…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...